title: Iris prolapse and the floppy-iris syndrome.
authors.forename: Katelyn J Y
authors.initials: KJ
authors.lastname: Lee
authors.forename: Edwin C
authors.initials: EC
authors.lastname: Figueira
authors.forename: Neil S
authors.initials: NS
authors.lastname: Sharma
authors.forename: Katherine
authors.initials: K
authors.lastname: Masselos
authors.forename: Ju-Lee
authors.initials: JL
authors.lastname: Ooi
authors.forename: Derek G
authors.initials: DG
authors.lastname: Chan
authors.forename: Ian C
authors.initials: IC
authors.lastname: Francis
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects; D006801:Humans; D007431:Intraoperative Complications; D007498:Iris / Q000187:drug effects*; D007499:Iris Diseases / Q000139:chemically induced* / Q000517:prevention & control; D008297:Male; D018918:Phacoemulsification / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects*; D013577:Syndrome; D000077409:Tamsulosin
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D000970:Antineoplastic Agents; D013449:Sulfonamides; D000077409:Tamsulosin